Moreover, A1AT augmentation therapy can have beneficial effects on wound healing in humans, reducing inflammation and preventing tissue damage28 and low serum levels of A1AT have been implicated in liver cancer, bladder cancer, gall bladder cancer, malignant lymphoma, and lung cancer29. This evidence concerns the gene SERPINA1 and urinary bladder cancer.